Merck & Co., Inc. (MRK) And Palantir Technologies Inc Agree On Cancer Data Analysis Pact
Palantir Technologies Inc and Merck & Co., Inc. (NYSE:MRK) German parent Merck KGaA have entered into a deal that will see them work together on a cancer data analytics project. This comes at a time when the use of technology for improved drug discovery is being adopted across the pharmaceutical industry. However, each of the […]